During a meeting last week [July 23-24], the Food and Drug Administration's Pharmacy Compounding Advisory Committee recommended that six previously restricted peptides be made available for pharmacy compounding.

Peptides are short chains of amino acids, the building blocks of proteins. Compounding is the preparation of customized medications for individual patients rather than the dispensing of conventionally manufactured, FDA-approved drugs.

The committee endorsed BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax—substances promoted for conditions ranging from ulcerative colitis and wound healing to obesity, osteoporosis, insomnia and neurological disorders. Only emideltide was rejected, 7-6.

Continue to the full article  |  More articles

PLEASE NOTE: The excellent photos that accompany this article did not transfer well, so to view it, please go to https://geneticliteracyproject.org/2026/07/30/hiroshima-at-81-americas-new-nuclear-bomb-a-buried-iranian-target-and-a-question-no-one-wants-to-ask/

(No paywall.)

Continue to the full article  |  More articles

Few people doubt that artificial intelligence (AI) will transform our lives. AI is already changing how we write, program computers, diagnose disease, design products, conduct scientific research, and even perpetrate scams. It may ultimately prove to be as important as electricity, the automobile, or the internet.

But there is another question that deserves equal attention: Is today's enormous investment in AI justified by the value it will ultimately create?

Continue to the full article  |  More articles

Please view the article here. (No paywall!)

Continue to the full article  |  More articles

On quiet, residential streets in Sterling, Virginia, residents often wake to the roar of diesel backup generators and smog that leaves their throats raw by morning — the price of AI data centers built without proper zoning oversight.

Continue to the full article  |  More articles